HR 311 United States House · 117th Congress

To provide for quality assurance of COVID-19 reimbursements and reporting.

Summary
This bill (1) establishes documentation requirements for testing, treatment, and reporting related to COVID-19 (i.e., coronavirus disease 2019); and (2) makes it unlawful to knowingly report a false diagnosis of COVID-19. To receive a federal reimbursement for the cost of a COVID-19 diagnostic test or treatment, the request for reimbursement must document that the administered COVID-19 test has been approved, cleared, or authorized by the Food and Drug Administration. Further, the Centers for Disease Control and Prevention must exclude from its official COVID-19 case and death counts any person who tested positive and requested federal reimbursement without the required documentation. Additionally, any person who knowingly reports a false diagnosis of COVID-19 is subject to criminal fines and imprisonment for not more than 10 years.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2021
Committee Review
Floor Vote
President
Introduced Jan 13, 2021 Last action Mar 5, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
3
Mar 5, 2021
Committee
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
lower
Feb 2, 2021
Committee
Referred to the Subcommittee on Health.
lower
Jan 13, 2021
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Jan 13, 2021
Introduced
Introduced in House
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Bill Posey
Bill Posey
RRepublican
FL
8